NRSN logo

NeuroSense Therapeutics (NRSN) Enterprise Value

Enterprise Value

$26.27 M
+$231.26 K+0.89%

13 min ago


Summary


Performance

NRSN Enterprise Value Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

OtherNRSNvaluationmetrics:

Enterprise Value Formula

Enterprise Value = Market Cap + Total Debt − Cash & Cash Equivalents

NRSN Enterprise Value Trends

PeriodPeriodEnterprise valueEnterprise valueMarket capMarket capPricePrice
todaytoday+0.9%+0.9%+0.9%
1 m1 month+10.6%+10.4%+10.4%
3 m3 months+4.1%+4.1%-10.8%
6 m6 months+144.9%+123.5%+74.5%
ytdytd-2.6%-2.5%-2.5%
1 y1 year+54.2%+36.1%-9.5%
5 y5 years---

NRSN Enterprise Value Highs & Lows

PeriodPeriodHighHighCurrent vs highvs highLowLowCurrent vs lowvs low
1 m1-month-6.5%$23 M+12.9%
3 m3-month$32 M-16.8%$18 M+47.3%
6 m6-month$32 M-16.8%$10 M+157.5%
1 y1-year$32 M-17.7%$10 M+157.5%
3 y3-year$57 M-54.0%$1.20 M+2086.6%
5 y5-year$57 M-54.0%$1.20 M+2086.6%
alltimeall time$57 M-54.0%$1.20 M+2086.6%

NeuroSense Therapeutics Enterprise Value History

DateValue
2025
$26.27 M(-2.6%)
2024
$26.96 M(+173.0%)
DateValue
2023
$9.88 M(-10.5%)
2022
$11.04 M(-30.4%)
2021
$15.86 M

FAQ

  • What is NeuroSense Therapeutics enterprise value?
  • What is the all time high enterprise value for NeuroSense Therapeutics?
  • What is NRSN enterprise value year-to-date change?
  • What is NeuroSense Therapeutics enterprise value year-on-year change?

What is NeuroSense Therapeutics enterprise value?

The current enterprise value of NRSN is $26.27 M

What is the all time high enterprise value for NeuroSense Therapeutics?

NeuroSense Therapeutics all-time high enterprise value is $57.12 M

What is NRSN enterprise value year-to-date change?

NeuroSense Therapeutics enterprise value has changed by -$693.78 K (-2.57%) since the beginning of the year

What is NeuroSense Therapeutics enterprise value year-on-year change?

Over the past year, NRSN enterprise value has changed by +$9.23 M (+54.20%)